I don't see that happening. They raised not too long ago. And, I think, they have a good shot at a lucrative partnership before the end of the year. (I'm not sure if a prospective partner really needs to see the final data, probably out by the end of the year.)
Dr. Davis, CMO, said that CLDX would take the drug into Phase III, with or without a partner. LOLOL. I think he's just blowing smoke.